.ashx?bid=4a2e5ebb5bdb40cab633b8e28e053c66)
merged with
June 2021
$1,534,600,000
Financial Advisor
NASDAQ: GOODO| June 2021
$96,950,000
Follow on offering
Co-Manager
TSE: EGLX| June 2021
$52,900,000
Follow on offering
Co-Manager
NASDAQ: SQFTP| June 2021
$20,000,000
Follow on offering
Co-Manager
merged with
May 2021
$651,000,000
Financial Advisor
acquired by
May 2021
$50,000,000
Financial Advisor
NASDAQ: HTIA | May 2021
$55,000,000
Follow on offering
Co-Manager
NASDAQ: CMCO | May 2021
$207,000,000
Follow on offering
Co-Manager
NASDAQ: NOTV | April 2021
$51,750,000
Follow on offering
Sole Book-Runner
NYSE: UCTT | April 2021
$200,000,000
Follow on offering
Co-Manager
NYSE: TLS | April 2021
$300,000,000
Follow on offering
Co-Manager
NYSE: CHFS | March 2021
$21,000,000
Follow on offering
Financial Advisor
NYSE: DGII | March 2021
$68,250,000
Follow on offering
Co-Manager
NYSE: ICAD | March 2021
$25,000,000
Follow on offering
Co-Manager
BIOL | February 2021
$14,400,000
Follow on offering
Joint Book Runner
NASDAQ: GRNV | February 2021
$300,000,000
Financial Advisor
NASDAQ: LTRN | January 2021
$69,000,000
Follow-On Offering
Co-Manager
NASDAQ: CRKN | January 2021
$19,000,000
Follow-On Offering
Co-Manager
Flowonix Medical
December 2020
$33,000,000
Private Placement
Sole Agent
NYSE: NSCO | December 2020
$140,000,000
Private Placement
Placement Agent
NASDAQ: TLS | November 2020
$254,500,000
Initial Public Offering
Co-Manager
NYSE: INVO| November 2020
$11,600,000
Follow-On Offering
Joint Book Runner
NYSE: OMCL | September 2020
$250,000,000
Private Placement
Co-Manager
NASDAQ: HGBL | September 2020
$9,559,375
Follow-On Offering
Joint Book Runner
NASDAQ: CXDO | September 2020
$15,400,000
Follow-On Offering
Joint Book Runner
Accountable Healthcare America acquired by GreenVision Acquisition Corp.
August 2020
Financial Advisor
NYSE: MOTS | August 2020
$10,000,000
Registered Direct
Financial Advisor
NASDAQ: OTRK | August 2020
$42,500,000
Preferred Stock Offering
Co-Manager
NASDAQ: BIOL | July 2020
$18,000,000
Rights Offering
Co-Manager
NASDAQ: MTBC | July 2020
$24,000,000
Preferred Stock Offering
Co-Manager
NASDAQ: LTRN | June 2020
$26,250,000
Initial Public Offering
Co-Manager
NASDAQ: BIOL | June 2020
$6,900,000
Registered Direct
Co-Manager
NYSE: MODN| May 2020
$172,500,000
Private Placement
Co-Manager
NASDAQ: CEMI | May 2020
$30,780,216
Follow-On Offering
Co-Manager
NYSE: UTI | February 2020
$52,565,000
Follow-On Offering
Co-Manager
NYSE: ALTG | February 2020
Financial Advisory
Financial Advisor
NASDAQ: MEDS | February 2020
$6,000,000
Follow-On Offering
Co-Manager
NYSE: MYO | February 2020
$15,000,000
Follow-On Offering
Co-Manager
NASDAQ: FUV | November 2019
$9,000,000
Follow-On Offering
Co-Manager
NASDAQ: QUMU | November 2019
$8,000,000
Follow-On Offering
Financial Advisor
NASDAQ: BIOL | October 2019
$5,170,975
Follow-On Offering
Co-Lead Underwriter
Allied Pacific IPA acquired by ApolloMed
September 2019
$545,000,000
Financial Advisor